Genomic Health, Inc. operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genomic Health with three other
pharmaceutical manufacturers in North America:
sales of $321.28 million
of which 55%
was Animal Safety),
Ionis Pharmaceuticals Inc
of which 104%
was Ionis core), and
Nature's Sunshine Products, Inc
of which 52%
was NSP Americas).
During the year ended December of 2016, sales at
Genomic Health were $327.87 million.
increase of 14.1%
versus 2015, when the company's sales were $287.46 million.
This was the fifth consecutive year of sales increases at Genomic Health
(and since 2011, sales have increased a total of 59%).